Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Decentralized Therapeutic Drug Monitoring of Taxanes and ALK Inhibitors in NSCLC: A Real-World Feasibility Study Using the True Dose Capillary Self-Sampling System

NCT07823725 is registered in ClinicalTrials.gov with Karolinska Institutet as lead sponsor.

NCT NCT07823725
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07823725 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Decentralized Therapeutic Drug Monitoring of Taxanes and ALK Inhibitors in NSCLC: A Real-World Feasibility Study Using the True Dose Capillary Self-Sampling System
Lead sponsor
Karolinska Institutet
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
October 1, 2029
Enrollment
40 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

non-small cell lung cancer (mesh term: carcinoma, non-small-cell lung)